API- Dactinomycin

Packaging- Single-use Vial

Strength- 0.5mg

Get an Enquiry


Dactinomycin is a chemotherapy medication indicated for the treatment of:

  • Wilms’ Tumor
  • Ewing’s Sarcoma
  • Rhabdomyosarcoma
  • Malignant Hydatidiform Mole
  • Gestational Trophoblastic Neoplasia

Dosage and Side Effects

Dacilon (Dactinomycin) should be given by injection into a vein.

  • Most common adverse reactions include vomiting, hair loss, infections, muscle pain and bone marrow suppression.
  • Some other serious Dactinomycin side effects include allergic reactions and tissue death at the site of injection

Warning and Precautions

  • Dactinomycin is highly toxic and both powder and solution must be handled and administered with care.
  • This medication should not be given at or about the time of infection with chickenpox or herpes zoster.
  • Actinomycin may cause fetal harm when administered to pregnant women. Women of childbearing potential must be warned to avoid becoming pregnant.
  • The greater frequency of toxic effects of this medication in infants suggests that this drug should be administered to infants only over the age of 6-12 months.


What kind of drug is Dactinomycin?

Dactinomycin is one of the actinomycins, a group of antibiotics produced by various species of Streptomyces. Dactinomycin is used as a chemotherapy drug in the treatment of many cancers.

How is Dactinomycin produced?

Dactinomycin is the active ingredient in the medicine produced by Streptomyces parvullus; this organism yields an essentially pure substance that contains only traces of similar compounds differing in the amino acid content of the peptide side chains.

What are all the ingredients in the medicine Dactinomycin?

Dactinomycin is the active ingredient in the medicine, and the inactive ingredient is mannitol.

How Dactinomycin 0.5 mg is given?

Dactinomycin is given through a vein (Intravenous).
Is Dactinomycin can be used for soft tissue sarcoma and ovarian cancer?
Yes, Dactinomycin can be used for soft tissue sarcoma and ovarian cancer.